OSAIC HOLDINGS, INC. - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,597,170
+8.3%
649,318
+7.7%
0.01%
-12.5%
Q2 2023$4,245,745
-9.4%
603,089
+7.3%
0.01%
-11.1%
Q1 2023$4,687,588
-28.1%
562,061
-1.0%
0.01%
-30.8%
Q4 2022$6,519,480
-9.8%
567,918
-1.0%
0.01%
-23.5%
Q3 2022$7,227,000
+16.4%
573,577
-2.3%
0.02%
+21.4%
Q2 2022$6,209,000
-33.5%
586,807
+2.2%
0.01%
-22.2%
Q1 2022$9,338,000
+20.3%
574,249
+2.5%
0.02%
+20.0%
Q4 2021$7,764,000
+6.1%
560,499
+10.0%
0.02%0.0%
Q3 2021$7,320,000
+11.3%
509,469
+22.5%
0.02%
+7.1%
Q2 2021$6,575,000
+66.3%
415,845
+7.0%
0.01%
+40.0%
Q1 2021$3,953,000
+68.5%
388,697
+23.5%
0.01%
+66.7%
Q4 2020$2,346,000
+315.2%
314,834
+91.3%
0.01%
+200.0%
Q3 2020$565,000
+20.0%
164,593
+66.5%
0.00%0.0%
Q2 2020$471,000
+823.5%
98,847
+284.3%
0.00%
Q1 2020$51,00025,7230.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Burrage Capital Management LLC 864,916$13,674,00013.71%
Sarissa Capital Management LP 4,261,000$67,366,0005.36%
ORACLE INVESTMENT MANAGEMENT INC 1,920,733$30,367,0004.18%
HealthCor Management, L.P. 3,248,100$51,352,0002.05%
Parkman Healthcare Partners LLC 351,961$5,565,0001.22%
Bain Capital Public Equity Management II, LLC 1,560,730$24,675,0001.06%
Baker Brothers Advisors 12,710,818$200,958,0000.88%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,835,000$44,821,0000.80%
Biondo Investment Advisors, LLC 265,840$4,203,0000.72%
EAM Global Investors LLC 157,065$2,483,0000.69%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders